4
Tetrahedron
8. (a) Karlsson, G. B.; Butters, T. D.; Dwek, R. A.; Platt, F. M. J. Biol.
mol%]. After completion of reaction, as indicated by TLC analysis, the
solid obtained was filtered, washed with ethanol, dried and re-crystallize
from ethanol to give pure product (4a). The assigned structures of the
products were established from their spectral and physical properties
and also by comparison with available literature data.
Chem. 1993, 268, 570; (b) Groopman, J. E. Rev. Infect. Dis. 1990, 12,
931.
9. (a) Treadway, J. L.; Mendys, P.; Hoover, D. J. Expert Opin. Invest.
Drugs 2001, 10, 439; (b) Jacob, G. S. Curr. Opin. Struct. Biol. 1995, 5,
605.
20. Typical experimental procedure for the synthesis of benzimidazole
10. (a) Khan, A. T.; Lal, M.; Khan, M. M. Tetrahedron Lett. 2010, 51,
4419; (b) Misra, M.; Pandey, S. K.; Pandey, V. P.; Pandey, J.; Tripathi,
R.; Tripathi, R. P. Bioorg. Med. Chem. 2009, 17, 625; (c) Khan, A. T.;
Khan, M. M.; Bannuru, K. K. R. Tetrahedron 2010, 66, 7762; (d) Khan,
A. T.; Parvin, T.; Choudhury, L. H. J. Org. Chem. 2008, 73, 8398; (e)
Agrawal, N. R.; Bahekar, S. P.; Sarode, P. B.; Zade, S. S.; Chandak, H.
S. RSC Adv. 2015, 5, 47053.
11. (a) Clarke, P. A.; Zaytzev, A. V.; Whitwood, A. C. Tetrahedron Lett.
2007, 48, 5209; (b) Wang, H.-J.; Mo, L.-P.; Zhang, Z.-H. ACS Comb.
Sci. 2011, 13, 181; (c) Mishra, S.; Ghosh, R. Tetrahedron Lett. 2011,
52, 2861; (d) Brahmachari, G.; Das, S. Tetrahedron Lett. 2012, 53,
1479; (e) Dindulkar, S. D.; Parthiban, P.; Jeong, Y. T. Monatsh. Chem.
Chem. Mon. 2012, 143, 113; (f) Mukhopadhyay, C.; Rana, S.; Butcher,
R. J.; Schmiedekamp, A. M. Tetrahedron Lett. 2011, 52, 5835; (g)
Leonova, E.; Makarov, M.; Klemenkova, Z.; Odinets, I. Helv. Chim.
Acta 2010, 93, 1990.
12. (a) Prajapti, S. K.; Nagarsenkar, A.; Babu, B. N. Tetrahedron Lett.
2014, 55, 3507; (b) Prajapti, S. K.; Nagarsenkar, A.; Babu, B. N.
Tetrahedron Lett. 2014, 55, 1784; (c) Nagarsenkar, A.; Prajapti, S. K.;
Babu, B. N. J. Chem. Sci. 2015, 127, 711; (d) Prajapti, S. K.; Gupta, K.
K.; Babu, B. N. J. Chem. Sci. 2015, 127, 1047; (e) Guggilapu, S. D.;
Prajapti, S. K.; Babu, B. N. Tetrahedron Lett. 2015, 56, 889; (f) Adduci,
L. L.; Bender, T. A.; Dabrowski, J. A.; Gagné, M. R. Nature Chem.
2015, 7, 576. (g) Nagarsenkar, A.; Prajapti, S. K.; Guggilapu, S. D.;
Babu, B. N. Org. Lett. 2015, 17, 4592.
derivatives:
A
mixture of benzaldehyde
1
(1 mmol), o-
phenylenediamine 5a (1 mmol) in EtOH (10 mL) was stirred
magnetically at room temperature in the presence of B(C6F5)3 [5 mol%].
After completion of reaction, as indicated by TLC analysis, the solid
obtained was filtered, washed with ethanol, dried and re-crystallize from
ethanol to give pure product (6a). The assigned structures of the
products were established from their spectral and physical properties
and also by comparison with available literature data.
21. Spectroscopic data of representative novel compounds: Methyl 2,6-
bis(3-((1-benzyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1-phenyl-4-
(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate
(4j):
Off
yellow solid, mp 80-82 °C; 1H NMR (500 MHz, DMSO-d6) δ 10.14
(1H, s), 8.22 (1H, s), 8.20 (1H, s), 7.38-7.28 (11H, m), 7.24-7.20 (3H,
m), 7.17-7.09 (3H, m), 7.02-6.98 (2H, m), 6.95-6.89 (2H, m), 6.85-6.83
(1H, m), 6.76-6.71 (1H, m), 6.54-6.50 (1H, m), 6.43-6.39 (3H, m), 6.27
(1H, s), 5.62-5.56 (6H, m), 5.07-4.98 (4H, m), 3.84 (3H, s), 2.94-2.89
(1H, m), 2.80-2.74 (1H, m); 13C NMR (125 MHz, DMSO-d6) 167.4,
158.1, 157.9, 154.8, 146.0, 145.7, 144.5, 142.8, 142.7, 137.4, 135.8,
129.4, 129.4, 128.8, 128.8, 128.7, 128.6, 128.0, 127.8, 127.8, 125.4,
124.9, 124.5, 124.5, 124.4, 118.6, 115.7, 112.8, 112.6, 112.1, 111.7,
97.1, 60.8, 60.7, 59.6, 56.3, 54.6, 52.7, 51.0, 39.6; IR (KBr)vmax 3321,
2925, 1651, 1592, 1498, 1251, 1034, 694 cm-1; HRMS m/z calcd. for
C51H46N8O4 [M+H]+: 835.3720; found: 835.3731. Ethyl 2,6-bis(3-((1-
benzyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1-phenyl-4-
(phenylamino)-1,2,5,6-tetrahydropyridine-3-carboxylate
(4o):
Off
13. (a) Yildiz-Oren, I.; Yalcin, I.; Aki-Sener, E.; Ucarturk, N. Eur. J. Med.
Chem. 2004, 39, 291; (b) Li, X. C.; Widdop, R. E. Hypertension 1995,
26, 989; (c) Evans, D. A.; Sacks, C. E.; Kleschick, W. A.; Taber, T. R.
J. Am. Chem. Soc. 1979, 101, 6789; (d) Kumar, D.; Jacob, M. R.;
Reynolds, M. B.; Kerwin, S. M. Bioorg. Med. Chem. 2002, 10, 3997;
(e) Benazzou, A.; Boraund, T.; Dubedat, P.; Boireau, J.M.; Stutzmann,
C. Eur. J. Pharmcol. 1995, 284, 299.
14. (a) Middleton, R.W.; Wibberley, D. G. J. Heterocycl. Chem. 1980, 17,
1757; (b) Czarny, A.; Wilson, W. D.; Boykin, D. W. J. Heterocycl.
Chem. 1996, 33, 1393; (c) Bourgrin, K.; Loupy, A.; Soufiaoui, M.
Tetrahedron 1998, 54, 8055.
15. (a) Yadagiri, B.; Lown, J. W. Synth. Commun. 1990, 20, 955; (b)
Vanden Eynde, J. J.; Delfosse, F.; Lor, P.; Van Haverbeke, Y.
Tetrahedron 1995, 51, 5813; (c) Nagawade, R. R.; Shinde, D. B. Chin.
Chem. Lett. 2006, 17, 453; (d) Gogoi, P.; Konwar, D. Tetrahedron Lett.
2006, 47, 79; (e) Jadhav, G. R.; Shaikh, M. U.; Kale, R. P.; Gill, C. H.
Chin. Chem. Lett. 2009, 20, 292; (f) Singh, M. P; Sasmal, S.; Lu, W.;
Chatterjee, M. N. Synthesis, 2000, 1380; (g) Patzold, F.; Zeuner, F.;
Heyer, T. H.; Niclas, H. J. Synth. Commun. 1992, 22, 281.
16. (a) Bhatnagar, I.; George, M. V. Tetrahedron 1968, 24, 1293; (b)
Stephens, F. F.; Bower, J. D. J. Chem. Soc. 1949, 2971; (c) Trivedi, R.;
De, S. K.; Gibbs, R. A. J. Mol. Catal. A: Chem. 2006, 245, 8; (d)
Massimo C.; Francesco E.; Francesca M. Synlett 2004, 1832.
17. (a) Beaulieu, P. L.; Hache, B.; Von Moos, E. Synthesis 2003, 1683; (b)
Austen, S. C.; Kane, J. M. J. Heterocycl. Chem. 2001, 38, 979; (c)
Dabhade, S. K.; Bora, R. O.; Farooqui, M.; Gill, C. H. Chin. Chem. Lett.
2009, 20, 893; (d) Shaterian, H. R.; Fahimi, N.; Azizi, K. Chin. J.
Chem. 2011, 29, 2389; (e) Xiangming, H.; Huiqiang, M.; Yulu, W.
Arkivoc 2007, 13, 150.
18. (a) Surpur, M. P.; Singh, P. R.; Patil, S. B.; Samant, S. D. Synth.
Commun. 2007, 37, 1375; (b) Nadaf, R. N.; Siddiqui, S. A.; Daniel T.;
Lahoti R. J.; Srinivasan K. V. J. Mol. Catal. A 2004, 214, 155; (c) Wu,
C. H.; Sun, C. M. Tetrahedron Lett. 2006, 47, 2601.
yellow solid, mp 72-74 °C; 1H NMR (500 MHz, DMSO-d6) δ 10.23
(1H, s), 8.24-8.20 (2H, m), 7.39-7.27 (11H, m), 7.26-7.08 (2H, m),
7.03-6.86 (7H, m), 6.82-6.72 (2H, m), 6.55-6.49 (1H, m), 6.44-6.39
(4H, m), 6.27 (1H, s), 5.62-5.55 (6H, m), 5.08-4.98 (4H, m), 4.38-4.33
(1H, m), 4.29-4.23 (1H, m), 2.97-2.92 (1H, m), 2.80-2.74 (1H, m), 1.33
(3H, t, J = 7.1 Hz); 13C NMR (125 MHz, DMSO-d6) 167.0, 158.1,
157.9, 154.8, 146.1, 145.9, 144.6, 142.8, 142.7, 137.4, 135.8, 129.5,
129.4, 128.8, 128.7, 128.6, 128.0, 127.8, 125.3, 124.7, 124.5, 124.5,
118.6, 118.6, 115.7, 112.7, 112.7, 112.6, 112.2, 111.8, 97.3, 60.8, 60.7,
59.3, 56.2, 52.7, 39.6, 14.5; IR (KBr)vmax 3345, 2933, 1648, 1592,
1497, 1245, 1033, 693 cm-1; HRMS m/z calcd. for C52H48N8O4
[M+Na]+:
871.3696;
found:
871.3707.
2-(3-((Tert-
butyldimethylsilyl)oxy)phenyl)-1H-benzo[d]imidazole (6m): White
1
solid, mp 251-253 °C; H NMR (300 MHz, DMSO-d6) δ 7.76 (1H, d, J
= 7.9 Hz), 7.63 (1H, t, J = 1.8 Hz), 7.57 (2H, dd, J = 3.0, 6.0 Hz), 7.31
(1H, t, J = 7.9 Hz), 7.17 (2H, dd, J = 3.2, 6.0 Hz), 6.86 (1H, m), 0.93
(9H, s), 0.16 (6H, s); 13C NMR (75 MHz, DMSO-d6) 155.4, 150.8,
138.3, 130.5, 129.4, 129.3, 122.0, 121.9, 121.2, 121.2, 121.0, 119.4,
117.9, 114.4, 25.1, 17.5, -5.4; IR (KBr)vmax 3422, 3055, 2929, 2857,
1600, 1448, 1241, 935, 835, 744 cm-1; HRMS m/z calcd. for
C19H24N2OSi [M+H]+: 325.1736; found: 325.1750. 2-(3-((Tert-
butyldiphenylsilyl)oxy)phenyl)-1H-benzo[d]imidazole (6n): Off white
solid, mp 212-214 °C; 1H NMR (300 MHz, CDCl3) δ 7.91 (1H, m), 7.76
(2H, dd, J = 3.2, 6.2 Hz), 7.7.0 (4H, m), 7.43 (10H, m), 6.71(1H, dd, J =
1.7, 8.1 Hz), 1.06 (9H, s); 13C NMR (75 MHz,CDCl3) 156.1, 151.1,
137.9, 135.4, 135.3, 135.2, 132.4, 129.9, 130.0, 127.8, 127.7, 123.2,
121.7, 119.8, 118.3, 114.9, 26.3, 19.3; IR (KBr)vmax 3432, 3050, 2928,
2855, 1585, 1446, 1427, 1232, 1105, 931, 736, 700 cm-1; HRMS m/z
calcd. for C29H29N2OSi [M+H]+: 449.2044; found: 449.2040. 2-(4-
Phenylthiophen-2-yl)-1H-benzo[d]imidazole (6r): Off white solid, mp
1
245-246 °C; H NMR (300 MHz, DMSO-d6) δ 8.26 (1H, s), 8.05 (1H,
s), 7.75 (2H, d, J = 7.36 Hz), 7.60 (2H, t, J = 4.15 Hz), 7.51 (2H, t, J =
7.36 Hz), 7.38 (1H, m), 7.22 (2H, m); 13C NMR (75 MHz, DMSO-d6)
146.7, 141.9, 134.5, 134.3, 128.9, 127.4, 125.7, 125.2, 123.4, 122.2; IR
(KBr)vmax 3430, 2936, 1448, 1426, 1406, 1226, 742 cm-1; HRMS m/z
calcd. for C17H12N2S [M+H]+: 277.0794; found: 277.0796.
19. Typical experimental procedure for the synthesis of functionalized
piperidines: A mixture of benzaldehyde 1 (1 mmol), aniline 2a (1
mmol), and methyl acetoacetate 3a (0.5 mmol) in EtOH (10 mL) was
stirred magnetically at room temperature in the presence of B(C6F5)3 [5